Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 221 | 1,484 | 428 | 436 | -25 |
| Cost of Goods | 1,172 | 1,659 | 1,095 | 1,166 | 782 |
| Gross Profit | -951 | -175 | -667 | -730 | -807 |
| Operating Expenses | 6,196 | 5,022 | 6,078 | 3,497 | 4,860 |
| Operating Income | -6,975 | -4,538 | -6,650 | -4,061 | -4,885 |
| Interest Expense | 1,044 | 884 | 757 | 321 | 562 |
| Other Income | -1,349 | -331 | 851 | -475 | 208 |
| Pre-tax Income | -9,368 | -5,753 | -6,556 | -4,857 | -5,239 |
| Net Income Continuous | -9,368 | -5,753 | -6,556 | -4,857 | -5,239 |
| Net Income | $-9,368 | $-5,753 | $-6,556 | $-4,857 | $-5,239 |
| EPS Basic Total Ops | -0.77 | -7.76 | -8.56 | -6.43 | -6.89 |
| EPS Basic Continuous Ops | -0.76 | -6.49 | -7.41 | -4.53 | -5.96 |
| EPS Diluted Total Ops | -0.77 | -7.76 | -8.56 | -6.43 | -6.89 |
| EPS Diluted Continuous Ops | -0.76 | -6.49 | -7.41 | -4.53 | -5.96 |
| EBITDA(a) | $-6,016 | $-3,589 | $-5,717 | $-3,545 | $-4,160 |